REVIEW article

Front. Pharmacol.

Sec. Inflammation Pharmacology

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1586364

This article is part of the Research TopicInfections in the Intensive Care Unit - Volume IIIView all 12 articles

The Key Players of Inflammasomes and Pyroptosis in Sepsis-Induced Pathogenesis and Organ Dysfunction

Provisionally accepted
Lujian  ZhuLujian Zhu1Minli  HuMinli Hu1Haoming  XuHaoming Xu2Hanglu  XuHanglu Xu1Binbin  RenBinbin Ren1Ruiyan  XuRuiyan Xu1Maodong  GuoMaodong Guo1Haijun  ChenHaijun Chen1Dehe  ZhangDehe Zhang1Hao  FangHao Fang1*
  • 1Jinhua Central Hospital, Jinhua, China
  • 2Hebei General Hospital, Shijiazhuang, Hebei Province, China

The final, formatted version of the article will be published soon.

Pyroptosis is an inflammatory form of cell death involving caspase-1 or caspase-4/5/11, initiated by inflammasomes or cytoplasmic endotoxins as part of the immune defense. It is specifically characterized by Gasdermin-mediated pore formation leading to cell lysis, pyroptosis also entails the release of pro-inflammatory cytokines. As a natural mechanism of the immune system, it activates in response to harmful stimuli to eliminate threats and facilitate tissue repair. However, excessive pyroptosis can lead to detrimental outcomes, such as infectious shock, multiple organ dysfunction syndrome (MODS), and increased susceptibility to secondary infections.Sepsis, an unchecked immune response to infection, remains a leading cause of MODS and death among critically ill patients. The pathogenesis of sepsis is complex and multifaceted, involving innate inflammation that kills infected cells and releases pro-inflammatory cytokines. Recent research has increasingly explored the link between pyroptosis and sepsis, focusing on its mechanisms, roles, and potential therapeutic targets. There has been significant advancement in understanding pyroptosis, highlighting its vital role in the development of sepsis. This review delves into the molecular and pathophysiological roles of inflammasomes and pyroptosis in sepsis, with a particular emphasis on the impact on specific organs such as the heart, lungs, liver, kidney and brain, aiming to identify new diagnostic markers and therapeutic targets for sepsis management.

Keywords: pyroptosis, NLRP3 inflammasome, caspase-1, Sepsis, Organ dysfunction

Received: 02 Mar 2025; Accepted: 24 Apr 2025.

Copyright: © 2025 Zhu, Hu, Xu, Xu, Ren, Xu, Guo, Chen, Zhang and Fang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Hao Fang, Jinhua Central Hospital, Jinhua, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.